Showing results (301-310 of 364) with videos related to
Sort By:
Pageof 37
NPJ Precision Oncology|November 11, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-scoreChristoph Arolt, Andreas H Scheel, Margaret Dugan, et al.Annals of Clinical and Translational Neurology|February 3, 2015
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20bJens Ingwersen, Til Menge, Britta Wingerath, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLCChristoph Arolt, Margaret Dugan, Robert Wild, et al.Lung Cancer (Amsterdam, Netherlands)|September 30, 2025
Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohortMatthias Scheffler, Lia Tzala, Karly Louie, et al.Plos One|January 12, 2013
Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinibMatthias Scheffler, Thomas Zander, Lucia Nogova, et al.Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinomaRichard Riedel, Sebastian Michels, Carina Heydt, et al.Proceedings of the National Academy of Sciences of the United States of America|March 8, 2017
Understanding band gaps of solids in generalized Kohn-Sham theoryJohn P Perdew, Weitao Yang, Kieron Burke, et al.Journal of Chemical Theory and Computation|December 9, 2015
GW100: Benchmarking G0W0 for Molecular SystemsMichiel J van Setten, Fabio Caruso, Sahar Sharifzadeh, et al.Journal of Magnetic Resonance Imaging : JMRI|May 25, 2021
Fully Automated MR Detection and Segmentation of Brain Metastases in Non-small Cell Lung Cancer Using Deep LearningStephanie T Jünger, Ulrike Cornelia Isabel Hoyer, Diana Schaufler, et al.NPJ Precision Oncology|June 7, 2018
ALKG1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumorSebastian Y F Michels, Andreas H Scheel, Thomas Wündisch, et al.Pageof 37